Addressing increasingly resistant drugs by infectious agents
Drug Target Review
SEPTEMBER 4, 2023
7,9 Dihydrofolate reductase-thymidylate synthase (DHFR) have been successfully exploited for the therapy of bacterial infections and other parasitic diseases such as malaria. 2011): State of the Art in African Trypanosome Drug Discovery, Current topic of medical chemistry. Doi: 10.3390/ijms20061484 Faria, J., Carolina, B.M.,
111 
Let's personalize your content